GlassScriptPhysician profile
Jeff Will Josma
NPI 1740609031
$11,019.46
in general payments reported to CMS, 2019-2025
21 companies · $2,439 in 2025
The $2,439 reported for 2025 was more than what 86% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,206 · 2020: $113 · 2021: $92.49 · 2022: $680 · 2023: $1,606 · 2024: $881 · 2025: $2,439.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,579 · Travel and Lodging: $2,347.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,579.44 |
| Travel and Lodging | $2,347.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $3,248.15 | 2019-2020 | |
| Abbott Laboratories | $1,750.57 | 2024-2025 | Proclaim, Infinity, Eterna |
| Vertos Medical, INC. | $1,566.14 | 2019-2024 | Mild Device Kit |
| Nevro Corp. | $1,348.80 | 2019-2024 | Senza |
| Genesys Orthopedics Systems, L.L.C. | $1,018.57 | 2023 | Sacroiliac Joint Fusion System |
| Spinal Simplicity, LLC | $630.20 | 2022-2025 | Ha Minuteman G3-R |
| Medtronic, INC. | $538.31 | 2022-2025 | Synchromedii, Intellis Adaptivestim |
| Revance Therapeutics, INC. | $209.88 | 2024-2025 | Daxxify |
| Boston Scientific Corporation | $145.16 | 2019-2025 | Clinical Trial Product, Intracept |
| Curonix LLC | $107.53 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Abbvie INC. | $90.02 | 2023-2025 | |
| Painteq LLC | $58.42 | 2024 | Painteq |
| Globus Medical, INC. | $55.33 | 2025 | Senza |
| Vertex Pharmaceuticals Incorporated | $52.07 | 2024-2025 | |
| Si-Bone, INC. | $48.15 | 2023-2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalu Medical, INC. | $44.25 | 2024 | Nalu Neurostimulation System |
| Depuy Synthes Sales INC. | $34.62 | 2024 | Monovisc |
| Bioventus LLC | $25.79 | 2025 | Gelsyn-3 |
| Galderma Laboratories, L.P. | $18.66 | 2025 | |
| Stryker Corporation | $18.64 | 2020 | |
| Stimwave Technologies Incorporated | $10.20 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeff Josma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.